Ве молиме користете го овој идентификатор да го цитирате или поврзете овој запис: http://hdl.handle.net/20.500.12188/12942
DC FieldValueLanguage
dc.contributor.authorHalimi Vesaen_US
dc.contributor.authorDaci Armonden_US
dc.contributor.authorSimona Stojanovskaen_US
dc.contributor.authorPanovska-Stavridis Irinaen_US
dc.contributor.authorMilena Stevanovicen_US
dc.contributor.authorFilipce Venkoen_US
dc.contributor.authorGrozdanova, Aleksandraen_US
dc.date.accessioned2021-05-31T12:21:23Z-
dc.date.available2021-05-31T12:21:23Z-
dc.date.issued2020-05-16-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/12942-
dc.language.isoenen_US
dc.publisherJournal of Pharmaceutical Policy and Practiceen_US
dc.titleCurrent regulatory approaches for accessing potential COVID-19 therapiesen_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.1186/s40545-020-00222-6-
item.grantfulltextopen-
item.fulltextWith Fulltext-
crisitem.author.deptFaculty of Pharmacy-
Appears in Collections:Faculty of Pharmacy: Journal Articles
Files in This Item:
File Опис SizeFormat 
s40545-020-00222-6.pdf488.99 kBAdobe PDFView/Open
Прикажи едноставен запис

Page view(s)

85
Last Week
0
Last month
checked on 20.7.2025

Download(s)

19
checked on 20.7.2025

Google ScholarTM

Проверете

Altmetric


Записите во DSpace се заштитени со авторски права, со сите права задржани, освен ако не е поинаку наведено.